RACHAEL ADGER: Open Payments
NPI 1306806443 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 8 payments from 7 companies in 2025. Trend: 2023 $179 · 2024 $937 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $40 |
| Daiichi Sankyo Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Exelixis Inc. | 1 | $25 |
| PharmaEssentia USA Corporation | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: IBRANCE, Enhertu, JEMPERLI, CABOMETYX, BESREMI, KISQALI.
Industry payments across AZ — which companies pay providers there.
